Skip to main content Accessibility help
×
Home
  • Print publication year: 2017
  • Online publication date: June 2017

Chapter 16 - Dyslipidemia

from Section 2.2 - Cardiovascular Health
a.Final Recommendation Statement: Lipid Disorders in Adults (Cholesterol, Dyslipidemia): Screening. US Preventive Services Task Force, June 2008. Available at: www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementFinal/lipid-disorders-in-adults-cholesterol-dyslipidemia-screening. Retrieved May 22, 2016.
b.American Academy of Family Physicians. Clinical practice guideline manual: Lipid disorders. Available at: www.aafp.org/patient-care/clinical-recommendations/all/lipid-disorders.html. Retrieved May 22, 2016.
c.Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: Summary report. Pediatrics. 2011 (Suppl 5):S213–56. Available at: http://pediatrics.aappublications.org.proxy.library.vcu.edu/content/128/Supplement_5/S213.long. Retrieved May 22, 2016.
d.Geoffrey, R.S., Baker, C., Barden, G.A. III et al. 2014 recommendations for pediatric preventive health care. Pediatrics. 2014, 133:568–70. Available at: http://pediatrics.aappublications.org.proxy.library.vcu.edu/content/133/3/568.long. Retrieved May 22, 2016.
e.Hagan, J.F., Shaw, J.S., Duncan, P., editors. 2008. Bright Futures: Guidelines for Health Supervision of Infants, Children, and Adolescents, 3rd edition. Elk Grove Village, IL: American Academy of Pediatrics. Available at: https://brightfutures.aap.org/materials-and-tools/guidelines-and-pocket-guide/Pages/default.aspx. Retrieved May 22, 2016.
f.Stone, N.J., Robinson, J.G., Lichtenstein, A.H. et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults. Circulation. 2014, 129:S145. Available at: http://circ.ahajournals.org/content/129/25_suppl_2/S1. Retrieved May 22, 2016.
1.Kochanek, K.D. et al. Deaths: Final data for 2009. Natl Vital Stat Rep. 2011, 60:1116.
2.Mosca, L. et al., Twelve-year follow-up of American women’s awareness of cardiovascular disease risk and barriers to heart health. Circ Cardiovasc Qual Outcomes. 2010, 3:120–7.
3.Roger, V.L. et al. Heart disease and stroke statistics – 2012 update: A report from the American Heart Association. Circulation. 2012, 125:e2e220.
4.Patel, S.A. et al. Cardiovascular mortality associated with 5 leading risk factors: National and state preventable fractions estimated from survey data. Ann Intern Med. 2015, 163:245–53.
5.Lin, J.S., O’Connor, E., Evans, C.V. et al. Behavioral counseling to promote a healthy lifestyle in persons with cardiovascular risk factors: A systematic review for the US Preventive Services Task Force. Ann Intern Med. 2014, 161:568–78.
6.Taylor, F., Huffman, M.D., Macedo, A.F. et al. Statins for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2013 (1):CD004816. doi: 10.1002/14651858.CD004816.pub5.
7.Writing Group, M. et al. Heart disease and stroke statistics – 2012 update: A report from the American Heart Association. Circulation. 2012, 125:e2e220.
8.Helfand, M. and Carson, S. Screening for Lipid Disorders in Adults: Selective Update of 2001 U.S. Preventive Services Task Force Review. Evidence Synthesis No. 49. Rockville, MD: Agency for Healthcare Research and Quality.
9.Goff, D.C. Jr. et al., 2013 ACC/AHA guideline on the assessment of cardiovascular risk: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014, 129:S4973.
10.Draft Recommendation Statement: Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication. US Preventive Services Task Force.